全文获取类型
收费全文 | 84072篇 |
免费 | 6340篇 |
国内免费 | 1555篇 |
专业分类
耳鼻咽喉 | 760篇 |
儿科学 | 4091篇 |
妇产科学 | 1579篇 |
基础医学 | 8433篇 |
口腔科学 | 1191篇 |
临床医学 | 10943篇 |
内科学 | 12772篇 |
皮肤病学 | 911篇 |
神经病学 | 2729篇 |
特种医学 | 2162篇 |
外国民族医学 | 3篇 |
外科学 | 10464篇 |
综合类 | 12245篇 |
预防医学 | 12415篇 |
眼科学 | 413篇 |
药学 | 6818篇 |
85篇 | |
中国医学 | 1773篇 |
肿瘤学 | 2180篇 |
出版年
2023年 | 1346篇 |
2022年 | 2098篇 |
2021年 | 3761篇 |
2020年 | 4079篇 |
2019年 | 2874篇 |
2018年 | 2722篇 |
2017年 | 2942篇 |
2016年 | 2983篇 |
2015年 | 3139篇 |
2014年 | 5600篇 |
2013年 | 6215篇 |
2012年 | 5245篇 |
2011年 | 5562篇 |
2010年 | 4150篇 |
2009年 | 3943篇 |
2008年 | 3725篇 |
2007年 | 3853篇 |
2006年 | 3761篇 |
2005年 | 3289篇 |
2004年 | 2954篇 |
2003年 | 2747篇 |
2002年 | 1716篇 |
2001年 | 1588篇 |
2000年 | 1274篇 |
1999年 | 1157篇 |
1998年 | 931篇 |
1997年 | 824篇 |
1996年 | 716篇 |
1995年 | 769篇 |
1994年 | 705篇 |
1993年 | 633篇 |
1992年 | 618篇 |
1991年 | 506篇 |
1990年 | 426篇 |
1989年 | 406篇 |
1988年 | 348篇 |
1987年 | 306篇 |
1986年 | 274篇 |
1985年 | 359篇 |
1984年 | 254篇 |
1983年 | 180篇 |
1982年 | 219篇 |
1981年 | 177篇 |
1980年 | 120篇 |
1979年 | 96篇 |
1978年 | 91篇 |
1977年 | 67篇 |
1976年 | 67篇 |
1975年 | 27篇 |
1973年 | 24篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
目的:探讨项目管理在降低呼吸重症监护室(RICU)环境物品表面多重耐药菌检出率中的应用效果。方法:采用目的抽样方法,选取医院呼吸与危重症医学科RICU 17张编制床位、32处高频接触环境物品表面及42名工作人员为观察对象。2019年1月—2019年3月实施RICU常规管理,2019年4月—2019年6月实施项目管理。比较项目管理前后RICU各类别工作人员手卫生依从率、RICU环境物品表面清洁合格率及多重耐药菌检出率。结果:在项目管理后RICU各类别工作人员手卫生依从率均高于项目管理前(P<0.05);项目管理后RICU环境物品表面清洁合格率较项目管理前升高(P<0.05);项目管理后多重耐药菌(MDRO)病人床单位及病区办公区域环境物体表面的耐甲氧西林金黄色葡萄球菌(MRSA)和耐碳青霉烯鲍曼不动杆菌(CRAB)检出率均较项目管理前降低(P<0.05)。结论:项目管理可有效提高RICU各类别工作人员手卫生依从性及环境物品表面清洁合格率,降低RICU环境物品表面多重耐药菌检出率。 相似文献
3.
4.
干燥通常作为软式消化内镜再处理环节中最后一个关键步骤,在医院感染控制中, 干燥与软式消化内镜的清洗、消毒或灭菌有着同等重要的地位,但现有的干燥方法尚不能完全保证达到安全要求。本文总结软式消化内镜干燥的研究现状,分析归纳影响软式消化内镜干燥效果的因素,有利于软式消化内镜干燥的储存方法,以及干燥效果的评价方法,以期为临床现有实践和未来研究提供一定的循证依据。 相似文献
5.
Anna Maria Spera 《World Journal of Virology》2022,11(5):275-282
With a 5.3% of the global population involved, hepatitis B virus (HBV) is a major public health challenge requiring an urgent response. After a possible acute phase, the natural history of HBV infection can progress in chronicity. Patients with overt or occult HBV infection can undergo HBV reactivation (HBVr) in course of immunosuppressive treatments that, apart from oncological and hem-atological diseases, are also used in rheumatologic, gastrointestinal, neurological and dermatological settings, as well as to treat severe acute respiratory syndrome coronavirus 2 infection. The risk of HBV reactivation is related to the immune status of the patient and the baseline HBV infection condition. The aim of the present paper is to investigate the risk of HBVr in those not oncological settings in order to suggest strategies for preventing and treating this occurrence. The main studies about HBVr for patients with occult hepatitis B infection and chronic HBV infection affected by non-oncologic diseases eligible for immunosuppressive treatment have been analyzed. The occurrence of this challenging event can be reduced screening the population eligible for immunosuppressant to assess the best strategies according to any virological status. Further prospective studies are needed to increase data on the risk of HBVr related to newer immunomodulant agents employed in non-oncological setting. 相似文献
6.
Wassan Nori 《World Journal of Clinical Cases》2022,10(30):11210-11213
Numerous risk variables, including age, medical co-morbidities, and deranged inflammatory response, lead to higher mortality in a senior population with coronavirus disease 2019. C-reactive protein (CRP), an acute phase inflammatory protein secreted by the liver, was tested in the elderly, showing a diagnostic and prognostic role. However, recent research has shed light on new applications for CRP in geriatrics. It was used as a follow-up marker and as a therapeutic target. Early and accurate identification of patients' risks may mitigate the devastation of the invading virus in older cases and permit the implementation of a quick treatment plan for those most likely to deteriorate. 相似文献
7.
8.
《Nutrition, metabolism, and cardiovascular diseases : NMCD》2022,32(1):21-31
AimThis review aims to summarize and discuss some of the most relevant clinical trials in epidemiology, diagnostics, and treatment of hypertension published in 2020 and 2021.Data synthesisThe trials included in this review are related to hypertension onset age and risk for future cardiovascular disease, reliability of different blood pressure monitoring methods, role of exercise-induced hypertension, treatment of hypertension in patients with SARS-CoV-2 infection, management of hypertension high-risk patient groups, e.g., in the elderly (≥80 years) and patients with atrial fibrillation, and the interplay between nutrition and hypertension, as well as recent insights into renal denervation for treatment of hypertension.ConclusionsHypertension onset age, nighttime blood pressure levels and a riser pattern are relevant for the prognosis of future cardiovascular diseases. The risk of coronary heart disease appears to increase linearly with increasing exercise systolic blood pressure. Renin-angiotensin system blockers are not associated with an increased risk for a severe course of COVID-19. In elderly patients, a risk-benefit assessment of intensified blood pressure control should be individually evaluated. A J-shaped association between cardiovascular disease and achieved blood pressure could also be demonstrated in patients with atrial fibrillation on anticoagulation. Salt restriction and lifestyle modification remain effective options in treating hypertensive patients at low cardiovascular risk. Sodium glucose co-transporter 2 inhibitors and Glucagon-like peptide-1 receptor agonists show BP-lowering effects. Renal denervation should be considered as an additional or alternative treatment option in selected patients with uncontrolled hypertension. 相似文献
9.
摘要: 目的 系统评价注射用头孢哌酮钠/舒巴坦钠(商品名:舒普深)在中国治疗临床感染的有效性和安全性。 方法 系
统检索万方、中国知网、维普、SinoMed、PubMed和Cochrane Library数据库,收集1978年至2019年7月4日公开发表的关于头孢
哌酮/舒巴坦在中国治疗临床感染方面的文献,按照纳入排除标准进行筛选,使用Stata 15.0和SAS 9.4软件进行荟萃(Meta)分析。
主要结局指标包括临床有效率与痊愈率,次要结局指标包括细菌清除率(株)与不良事件发生率。 结果 最终纳入110篇文献,其
中有82篇、87篇分别纳入有效率和痊愈率的Meta分析。结果显示,头孢哌酮/舒巴坦治疗临床感染的总有效率为80.3% [95%置信
区间(CI): 77.4%~83.0%],痊愈率为50.1% (95%CI: 45.1%~55.1%)。共38项研究报告了细菌清除率,结果显示细菌清除率为81.1%
(95%CI: 76.9%~84.9%)。62篇文献报告治疗中发生的不良事件例数,合计不良事件的发生率为7.4% (95%CI: 6.1%~8.9%),包括
血液系统不良事件、胃肠道不良事件、肝肾功能损害及皮肤不良事件等。与其他对照药物相比,头孢哌酮/舒巴坦治疗临床感染
的有效性和安全性良好。 结论 头孢哌酮/舒巴坦的临床应用效果较为可观,对治疗临床感染具有较高的价值,安全性好。但
临床应注意合理用药,加强对头孢哌酮/舒巴坦的不良事件监测,减少不良事件。 相似文献
10.
Pei-Sheng Lin 《Statistics in medicine》2022,41(1):146-162
Identifying transmission of hot spots with temporal trends is important for reducing infectious disease propagation. Cluster analysis is a particularly useful tool to explore underlying stochastic processes between observations by grouping items into categories by their similarity. In a study of epidemic propagation, clustering geographic regions that have similar time series could help researchers track diffusion routes from a common source of an infectious disease. In this article, we propose a two-stage scan statistic to classify regions into various geographic clusters by their temporal heterogeneity. The proposed scan statistic is more flexible than traditional methods in that contiguous and nonproximate regions with similar temporal patterns can be identified simultaneously. A simulation study and data analysis for a dengue fever infection are also presented for illustration. 相似文献